Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prediction Intervals01:03

Prediction Intervals

2.2K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
2.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Estimating Population Mean with Unknown Standard Deviation01:22

Estimating Population Mean with Unknown Standard Deviation

7.6K
In practice, we rarely know the population standard deviation. In the past, when the sample size was large, this did not present a problem to statisticians. They used the sample standard deviation s as an estimate for σ and proceeded as before to calculate a confidence interval with close enough results. However, statisticians ran into problems when the sample size was small. A small sample size caused inaccuracies in the confidence interval.
William S. Gosset (1876–1937) of the...
7.6K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

104
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
104

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Sakurajima Radish in Patients with Metabolic Syndrome: A Phase IIb Randomized, Three-Period Crossover Trial.

Nutrients·2026
Same author

Analysis of therapeutic strategy changes for patients with melanoma using a national dataset in Japan.

International journal of clinical oncology·2026
Same author

Antenatal Magnesium Sulfate for Tocolysis and Early Enteral Feeding in Preterm Infants: A Retrospective Cohort Study.

Pediatrics international : official journal of the Japan Pediatric Society·2026
Same author

Cross-sectional Associations of Serum Sodium, Potassium, and Chloride with Cognition in Patients on Hemodialysis: The Osaka Dialysis Complication Study (ODCS).

Kidney medicine·2026
Same author

The Impact of Continuous Renal Replacement Therapy Filters with Cytokine Adsorption Properties on Survival Outcomes: A Study Using Diagnosis Procedure Combination data.

Blood purification·2026
Same author

Early-Phase Oral Antiviral Use and Post-COVID-19 Condition in Outpatients.

JAMA network open·2026
Same journal

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
Same journal

An interpretable XGboost algorithm for predicting 30-day mortality in acute pancreatitis using routine biomarkers.

BMC medical research methodology·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Prognostic score-based model averaging approach for propensity score estimation.

Daijiro Kabata1,2,3, Elizabeth A Stuart4, Ayumi Shintani5

  • 1Center for Mathematical and Data Science, Kobe University, 1-1 Rokkodai-cho, Nada-ku, Kobe, Hyogo, 657-8501, Japan. daijiro.kabata@port.kobe-u.ac.jp.

BMC Medical Research Methodology
|October 4, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel model-averaging approach for propensity score (PS) estimation using prognostic scores. The proposed method, focusing on prognostic score balance, significantly reduces bias and variability in treatment effect estimates.

Keywords:
Causal inferenceMachine learningModel averagingPrognostic scorePropensity score

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Related Experiment Videos

Last Updated: Jun 11, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Area of Science:

  • Statistics
  • Epidemiology
  • Biostatistics

Background:

  • Traditional propensity score (PS) evaluation focuses on covariate balance, potentially overlooking predictive power for outcomes, leading to suboptimal bias reduction.
  • Prognostic scores, which incorporate covariate-outcome relationships, offer an alternative for evaluating covariate balance.
  • Standard PS model averaging methods may not optimize confounding adjustment; averaging based on prognostic score balance is proposed as a superior alternative.

Purpose of the Study:

  • To propose and evaluate a novel propensity score (PS) model averaging approach that utilizes prognostic score balance.
  • To demonstrate that averaging PS models based on prognostic score balance can reduce bias in treatment effect estimates.
  • To compare the performance of the proposed method against existing approaches through simulations and empirical data analysis.

Main Methods:

  • Conducted simulations and analyzed empirical observational data to compare treatment effect estimates.
  • Developed four candidate PS and prognostic score models using traditional and machine learning methods.
  • Employed model averaging for PS estimation, optimizing for treatment prediction accuracy, covariate balance, or prognostic score balance; used prognostic scores and model-averaged prognostic scores for balance assessment.

Main Results:

  • The proposed model-averaging approaches for PS estimation consistently demonstrated lower bias and less variability in treatment effect estimates compared to existing methods.
  • Utilizing optimally averaged prognostic scores as a balance metric significantly enhanced the robustness of weighted treatment effect estimates.
  • Both simulation and empirical analyses supported the superiority of the prognostic score-based model averaging approach.

Conclusions:

  • Prognostic score-based PS model averaging outperforms existing methods, yielding more robust treatment effect estimates.
  • The proposed method, using model-averaged prognostic scores as a balance metric, is recommended for various applications.
  • Application to complex, high-dimensional real-world data requires careful adjustments and complementary techniques to ensure accurate estimation.